FFRangio in Dual/Triple Vessel Disease

Share

chevron_left Newsroom

Feb. 03, 2020

Excellent diagnostic performance, with sensitivity, specificity and accuracy all above 92%; FFRangio was 40% faster that wire-based FFR

This prospective clinical study conducted at Gifu Heart Centre, Japan—evaluated the diagnostic performance of FFRangio in 50 patients with dual or triple vessel CAD compared to wire-based FFR.

Recent Articles

Learn how the CathWorks FFRangio System can impact your practice.

*Required

expand_lessBack to top of page

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions

Accept